Saturday, 24 October 2026
Bulk-billing incentive payments, Melanoma mRNA vaccine results, Rural specialist training reforms paused
- 01
Bulk-billing incentive payments reached $192.3 million in eight months
Payments to practices and GPs under the Bulk Billing Practice Incentive Payment program reached $192.3 million in its first eight months, according to Services Australia’s latest annual report. By the end of June, 3600 practices had registered for the initiative, which began in November, with payments split evenly between clinics and GPs. The average payment was $53,416 per registered general practice. Over the same period, MyMedicare participation more than doubled from 3.2 million to 6.5 million patients, while registered practices increased from 6700 to 7600. Practices must participate in MyMedicare to receive BBPIP payments.
via RACGP newsGP
- 02
Personalised mRNA vaccine reduced melanoma recurrence risk in phase 3
The phase 3 trial found that personalised mRNA vaccine intismeran autogene plus pembrolizumab reduced the relative risk of recurrence or death by 42% compared with pembrolizumab alone in advanced melanoma after tumour removal. After a median 24.6 months, the combination also reduced the relative risk of cancer spreading to distant organs or tissues by 38%. Overall side-effect rates were similar, although fever and injection-site pain occurred substantially more often with intismeran, and 7% discontinued treatment because of an adverse event versus 5% in the comparator group. The findings marked a potential advance over PD-1 inhibitor treatment alone and showed that an individualised neoantigen therapy targeting up to 34 tumour-specific proteins could work in melanoma. Its impact in other cancers and earlier-stage disease remains uncertain, with studies under way in lung, bladder and kidney cancer.
via BioPharma Dive
- 03
Rural non-GP specialist training reform paused despite college backing
Work on proposed reforms to expand non-GP specialist training in rural settings has been paused, despite medical colleges presenting the federal government with three options and signalling readiness to proceed. Council of Presidents of Medical Colleges Associate Professor Kerin Fielding described the work as shelved, while a Department of Health, Disability and Ageing senior medical adviser said it had been paused. The current Specialist Training Program accounts for around 7% of non-GP specialist training places, compared with National Rural Health Commissioner Professor Jenny May’s view that around 30% of training must occur rurally to improve access. Associate Professor Fielding said much of the existing program’s funding had gone to metropolitan settings, while former ACRRM president Dr Rod Martin identified state funding of training posts as a major barrier. The CPMC has recently been invited to co-chair a short-term departmental committee examining the advanced non-GP specialist training workforce.
- 04
E-scooter hospitalisations triple as doctors seek tougher age limits
E-scooter hospitalisation rates tripled between 2019–20 and 2024–25 to 15 per 100,000 population, new Australian Institute of Health and Welfare data showed. Boys aged 12–15 had the highest rate, at 54 per 100,000, and were four times more likely than girls to be hospitalised after a fall. Injuries also became more severe, with fractures comprising 58% of cases in 2024–25, while intensive care admissions rose from 16 in 2015–16 to 73 in 2024–25. Queensland and Western Australia recorded the highest hospitalisation rates among young people, and e-scooter collisions hospitalised 164 pedestrians in 2024–25. AMA Queensland continues to call for a total ban on e-mobility devices for children under 16, arguing that the state’s tightened laws still leave younger riders at risk under parental supervision.
- 05
Nigeria confirms first Bundibugyo Ebola case in 12 years
Nigeria confirmed its first Ebola Bundibugyo virus disease case in 12 years, becoming the fifth country affected by an outbreak that has killed thousands. The patient, a woman who had travelled from Uganda, sought care at a private Abuja clinic on 11 October and tested positive on 20 October. The World Health Organization said she was in isolation and receiving care while investigations examined her likely source of infection and full travel and exposure history. Nigeria’s Ministry of Health said 44 contacts had been identified and were being monitored. Kenya also recorded its first infection earlier in October in a citizen who had travelled from the Democratic Republic of Congo.
via BMJ
- 06
NICE conditionally recommends five AI tools for prostate MRI
Five AI tools that help identify possible prostate cancer on MRI will be made available to NHS doctors while further evidence is generated, NICE has announced. The technologies highlight areas on prostate MRI scans where cancer might be present to support radiologists. NICE said they have the potential to improve the accuracy and consistency of MRI interpretation, particularly where specialist expertise is unavailable. However, it said more evidence was needed on their accuracy and performance in routine NHS practice. Independent experts welcomed the announcement but said assessments must also examine whether the algorithms could contribute to overdiagnosis.
via BMJ
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.